Team:Tec-Monterrey/projectresults/methods
From 2011.igem.org
(Difference between revisions)
(7 intermediate revisions not shown) | |||
Line 518: | Line 518: | ||
- | + | <p><a href="https://2011.igem.org/Team:Tec-Monterrey/projectoverview">overview</a></p> | |
<p><a href="https://2011.igem.org/Team:Tec-Monterrey/projectparts">parts</a></p> | <p><a href="https://2011.igem.org/Team:Tec-Monterrey/projectparts">parts</a></p> | ||
<p><a href="https://2011.igem.org/Team:Tec-Monterrey/projectmodeling">genetic frame</a></p> | <p><a href="https://2011.igem.org/Team:Tec-Monterrey/projectmodeling">genetic frame</a></p> | ||
- | <p><a href="https://2011.igem.org/Team:Tec-Monterrey/projectresults">methods | + | <p><a href="https://2011.igem.org/Team:Tec-Monterrey/projectresults/methods">methods</a></p> |
+ | <p><a href="https://2011.igem.org/Team:Tec-Monterrey/projectresults">results</a></p> | ||
<p><a href="https://2011.igem.org/Team:Tec-Monterrey/teamha">human approach</a></p> | <p><a href="https://2011.igem.org/Team:Tec-Monterrey/teamha">human approach</a></p> | ||
<p><a href="https://2011.igem.org/Team:Tec-Monterrey/projectprotocols">protocols</a><p> | <p><a href="https://2011.igem.org/Team:Tec-Monterrey/projectprotocols">protocols</a><p> | ||
Line 606: | Line 607: | ||
<center> | <center> | ||
- | CelD+estA Construction | + | <b>1.1. CelD+estA Construction</b> |
</center> | </center> | ||
Line 618: | Line 619: | ||
<center> | <center> | ||
- | CelD+estA Expression | + | <b>1.2. CelD+estA Expression</b> |
</center> | </center> | ||
<br> | <br> | ||
Line 627: | Line 628: | ||
- | + | <br> | |
<br> | <br> | ||
<center> | <center> | ||
- | + | <b>1.3. CelD+estA Activity</b> | |
</center> | </center> | ||
<br> | <br> | ||
<p class="textojustif"> | <p class="textojustif"> | ||
- | The IUPAC Filter Paper Assay was used to determine the celD+estA activity. The <i> | + | The IUPAC Filter Paper Assay was used to determine the celD+estA activity. The <i>E. coli</i> strain , Rosetta Gami, was used as a host for the expression of the chimeric protein because it has an improved protein folding system. The assay was applied to the whole-cells, but these were also lysated with x-Tractor Cell lysis Buffer (Clontech), which separated them into soluble and insoluble fractions. The negative controls (C-) of all the samples were non-transformed cells. In the whole-cell cellulase activity experiment and in the cellulase activity of cell-lysates experiment, a t-test was done with an alpha of 0.05 to prove the hypothesis. |
</p> | </p> | ||
Line 645: | Line 646: | ||
<br> | <br> | ||
<center> | <center> | ||
- | SacC Amplification | + | <b>2.1. SacC Amplification</b> |
</center> | </center> | ||
<br> | <br> | ||
Line 657: | Line 658: | ||
<center> | <center> | ||
- | OmpA+sacC Construction | + | <b>2.2. OmpA+sacC Construction</b> |
</center> | </center> | ||
<br> | <br> | ||
<p class="textojustif"> | <p class="textojustif"> | ||
- | The ompA+sacC construction was generated by joining the biobricks of the araC-P<sub>BAD</sub> promoter (<a href="http://partsregistry.org/Part:BBa_I13458">BBa_I13458 </a>and <a href="http://partsregistry.org/Part:BBa_K206000"> BBa_K206000</a>), RBS (<a href="http://partsregistry.org/Part:BBa_B0034">BBa_B0034</a>), lpp+ompA (<a href="http://partsregistry.org/Part:BBa_K103006">BBa_K103006</a>), and sacC (<a href="http://partsregistry.org/Part:BBa_K633003">BBa_K633003</a>) with the biobrick standard assembly protocol (<a href="http://ginkgobioworks.com/support/BioBrick_Assembly_Manual.pdf"> Manual</a>). The expected DNA fragment of the ompA + sacC construct was confirmed by several restriction endonuclease reactions, and used to transform the | + | The ompA+sacC construction was generated by joining the biobricks of the araC-P<sub>BAD</sub> promoter (<a href="http://partsregistry.org/Part:BBa_I13458">BBa_I13458 </a>and <a href="http://partsregistry.org/Part:BBa_K206000"> BBa_K206000</a>), RBS (<a href="http://partsregistry.org/Part:BBa_B0034">BBa_B0034</a>), lpp+ompA (<a href="http://partsregistry.org/Part:BBa_K103006">BBa_K103006</a>), and sacC (<a href="http://partsregistry.org/Part:BBa_K633003">BBa_K633003</a>) with the biobrick standard assembly protocol (<a href="http://ginkgobioworks.com/support/BioBrick_Assembly_Manual.pdf"> Manual</a>). The expected DNA fragment of the ompA + sacC construct was confirmed by several restriction endonuclease reactions, and used to transform the <i>E. coli</i> strains BL21SI, Rosetta Gami, XL1 Blue, C43 and BW27783. |
</p> | </p> | ||
<br> | <br> | ||
Line 669: | Line 670: | ||
<center> | <center> | ||
- | OmpA+sacC Expression | + | <b>2.3. OmpA+sacC Expression</b> |
</center> | </center> | ||
Line 684: | Line 685: | ||
<center> | <center> | ||
- | SacC Enzymatic Assays | + | <b>2.4. SacC Enzymatic Assays</b> |
</center> | </center> | ||
<br> | <br> | ||
<p class="textojustif"> | <p class="textojustif"> | ||
- | ... | + | To determine the ompA+sacC activity, EnzyChromTM Fructose Assay Kit (kindly donated by PhD. Fernández) was used. The <i>E. coli</i> BL21 SI was used for the expression of the fusion protein. The assay was applied to the whole-cells, and non-transformed cells were used as a negative control. A t-test was done with an alpha value of 0.05 to compare fructose concentrations of each sample. |
- | + | ||
- | < | + | |
</p> | </p> | ||